Coinhibitory pathways in the B7-CD28 ligand-receptor family

FA Schildberg, SR Klein, GJ Freeman, AH Sharpe - Immunity, 2016 - cell.com
Immune responses need to be controlled for optimal protective immunity and tolerance.
Coinhibitory pathways in the B7-CD28 family provide critical inhibitory signals that regulate …

B lymphocytes and cancer: a love–hate relationship

GJ Yuen, E Demissie, S Pillai - Trends in cancer, 2016 - cell.com
B Lymphocytes and Cancer: A Love–Hate Relationship: Trends in Cancer Skip to Main Content
Advertisement Trends in Cancer This journal offers authors two options (open access or …

Leveraging self-assembled nanobiomaterials for improved cancer immunotherapy

MP Vincent, JO Navidzadeh, S Bobbala, EA Scott - Cancer Cell, 2022 - cell.com
Nanomaterials and targeted drug delivery vehicles improve the therapeutic index of drugs
and permit greater control over their pharmacokinetics, biodistribution, and bioavailability …

Pituitary expression of CTLA-4 mediates hypophysitis secondary to administration of CTLA-4 blocking antibody

S Iwama, A De Remigis, MK Callahan… - Science translational …, 2014 - science.org
Hypophysitis is a chronic inflammation of the pituitary gland of unknown (primary forms) or
recognizable (secondary forms) etiology, such as the use of ipilimumab in cancer …

Beyond T-cells: functional characterization of CTLA-4 expression in immune and non-immune cell types

D Oyewole-Said, V Konduri, J Vazquez-Perez… - Frontiers in …, 2020 - frontiersin.org
The immune response consists of a finely-tuned program, the activation of which must be
coupled with inhibitory mechanisms whenever initiated. This ensures tight control of …

At the bench: preclinical rationale for CTLA-4 and PD-1 blockade as cancer immunotherapy

AM Intlekofer, CB Thompson - Journal of leukocyte biology, 2013 - academic.oup.com
Tumors can avoid immune surveillance by stimulating immune inhibitory receptors that
function to turn off established immune responses. By blocking the ability of tumors to …

A molecular perspective of CTLA-4 function

WA Teft, MG Kirchhof, J Madrenas - Annu. Rev. Immunol., 2006 - annualreviews.org
Within the paradigm of the two-signal model of lymphocyte activation, the interest in
costimulation has witnessed a remarkable emergence in the past few years with the …

The regulation of immunoglobulin E class-switch recombination

RS Geha, HH Jabara, SR Brodeur - Nature Reviews Immunology, 2003 - nature.com
Immunoglobulin E (IgE) isotype antibodies are associated with atopic disease, namely
allergic rhinitis, asthma and atopic dermatitis, but are also involved in host immune defence …

The B7: CD28 family and friends: Unraveling coinhibitory interactions

KP Burke, A Chaudhri, GJ Freeman, AH Sharpe - Immunity, 2024 - cell.com
Immune responses must be tightly regulated to ensure both optimal protective immunity and
tolerance. Costimulatory pathways within the B7: CD28 family provide essential signals for …

Ipilimumab treatment results in an early decrease in the frequency of circulating granulocytic myeloid-derived suppressor cells as well as their Arginase1 production

YP de Coaña, I Poschke, G Gentilcore, Y Mao… - Cancer immunology …, 2013 - AACR
Blocking the immune checkpoint molecule CTL antigen-4 (CTLA-4) with ipilimumab has
proven to induce long-lasting clinical responses in patients with metastatic melanoma. To …